Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis
Condition(s):Multi-drug Resistant TuberculosisLast Updated:November 4, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Multi-drug Resistant TuberculosisLast Updated:November 4, 2022Recruiting
Condition(s):Tuberculosis, Multidrug-ResistantLast Updated:February 16, 2023Recruiting
Condition(s):Drug-resistant Tuberculosis; HIV Coinfection; Cost-Benefit AnalysisLast Updated:January 23, 2024Not yet recruiting
Condition(s):MDR Tuberculosis; Resistance to Tuberculostatic DrugsLast Updated:October 27, 2020Completed
Condition(s):Tuberculosis, Multidrug-ResistantLast Updated:November 1, 2019Completed
Condition(s):TuberculosisLast Updated:April 24, 2015Completed
Condition(s):Tuberculosis, PulmonaryLast Updated:May 18, 2016Unknown status
Condition(s):Pneumonia; Pulmonary TuberculosisLast Updated:March 4, 2008Completed
Condition(s):Multi-drug Resistant Tuberculosis; Extensively Drug Resistant TuberculosisLast Updated:October 2, 2012Completed
Condition(s):Tuberculosis InfectionLast Updated:November 15, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.